TP53 and leukemia: This conclusion would be backed by the report from Chen et al., where TP53-deficient mice only developed leukemia after transplantation of hematopoietic stem cells with concomitant Kmt2c and Nf1-knockdown [19], pointing to a collaboration of several pathways promoting leukemogenesis in a multistep manner.